Without properly functioning collagen, the kidneys gradually lose their ability to filter waste products and maintain normal fluid balance within the body.
The disease primarily affects the glomerular basement membrane, a critical part of the kidney responsible for filtering toxins and waste from the blood. As the condition progresses, the kidney tissue becomes damaged and scarred, eventually leading to chronic kidney disease and kidney failure. XLHN is considered a progressive condition, meaning symptoms typically worsen over time.
Dogs affected by X-linked Hereditary Nephritis often begin showing signs at a young age, although the age of onset and severity can vary depending on the individual dog and breed. Early symptoms may include increased thirst, frequent urination, weight loss, poor appetite, lethargy, vomiting, and slowed growth in young dogs. As kidney function declines, affected dogs may develop dehydration, weakness, anemia, high blood pressure, and severe kidney failure. In advanced cases, the disease can become life-threatening.
Because XLHN is inherited in an X-linked pattern, male dogs are generally more severely affected than females. Male dogs have only one X chromosome, so inheriting a single copy of the mutated gene is enough to cause the disease. Female dogs possess two X chromosomes and may be carriers if they inherit only one mutated copy. Carrier females may show mild or delayed symptoms or may remain clinically normal while still passing the mutation to their offspring.
X-linked Hereditary Nephritis is caused by mutations in genes responsible for collagen production, particularly the COL4A5 gene. Defective collagen weakens the kidney filtration barrier, allowing proteins and blood cells to leak into the urine. One of the earliest detectable signs of the disease is persistent protein loss in the urine, known as proteinuria. Veterinary examination and laboratory testing may also reveal abnormal kidney values and reduced kidney function.
The XLHN genetic test is designed to identify whether a dog is genetically clear, a carrier, or affected by the mutation associated with the disorder. Testing is usually performed using a cheek swab or blood sample, which is analyzed in a specialized laboratory. Genetic screening provides accurate results even before symptoms develop, allowing breeders and owners to make informed health and breeding decisions.
Responsible breeding practices are essential for reducing the occurrence of XLHN within affected breeds. Breeding carrier females or affected males can result in puppies inheriting the disease. By testing breeding dogs before mating, breeders can avoid high-risk pairings and help protect future generations from developing this severe kidney disorder.
Currently, there is no cure for X-linked Hereditary Nephritis. Treatment focuses on supportive care aimed at slowing disease progression and improving quality of life. Veterinary management may include special kidney diets, medications to control blood pressure and protein loss, fluid therapy, and regular monitoring of kidney function. Early diagnosis is important because it allows veterinarians to begin supportive care before severe kidney damage occurs.
Testing for XLHN demonstrates a commitment to responsible dog ownership and ethical breeding. Identifying affected and carrier dogs helps improve breed health, supports informed breeding programs, and contributes to the long-term welfare of dogs at risk for this inherited kidney disease.
